The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
CpG Methylation Controls Reactivation of HIV from Latency
Open accessAbstract
DNA methylation of retroviral promoters and enhancers localized in the provirus 5' long terminal repeat (LTR) is considered to be a mechanism of transcriptional suppression that allows retroviruses to evade host immune responses and antiretroviral drugs. However, the role of DNA methylation in the control of HIV-1 latency has never been unambiguously demonstrated, in contrast to the apparent importance of transcriptional interference and chromatin structure, and has never been studied in HIV-1-infected patients. Here, we show in an in vitro model of reactivable latency and in a latent reservoir of HIV-1-infected patients that CpG methylation of the HIV-1 5' LTR is an additional epigenetic restriction mechanism, which controls resistance of latent HIV-1 to reactivation signals and thus determines the stability of the HIV-1 latency. CpG methylation acts as a late event during establishment of HIV-1 latency and is not required for the initial provirus silencing. Indeed, the latent reservoir of some aviremic patients contained high proportions of the non-methylated 5' LTR. The latency controlled solely by transcriptional interference and by chromatin-dependent mechanisms in the absence of significant promoter DNA methylation tends to be leaky and easily reactivable. In the latent reservoir of HIV-1-infected individuals without detectable plasma viremia, we found HIV-1 promoters and enhancers to be hypermethylated and resistant to reactivation, as opposed to the hypomethylated 5' LTR in viremic patients. However, even dense methylation of the HIV-1 5'LTR did not confer complete resistance to reactivation of latent HIV-1 with some histone deacetylase inhibitors, protein kinase C agonists, TNF-alpha, and their combinations with 5-aza-2deoxycytidine: the densely methylated HIV-1 promoter was most efficiently reactivated in virtual absence of T cell activation by suberoylanilide hydroxamic acid. Tight but incomplete control of HIV-1 latency by CpG methylation might have important implications for strategies aimed at eradicating HIV-1 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
Mattapallil, J. J., Douek, D. C., Hill, B., Nishimura, Y., Martin, M., & Roederer, M. (2005) · Nature · doi:10.1038/nature03501 · Cited by 1,278
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
Li, Q., Duan, L., Estes, J. D., Ma, Z.-M., Rourke, T., Wang, Y., Reilly, C., Carlis, J., Miller, C. J., & Haase, A. T. (2005) · Nature · doi:10.1038/nature03513 · Cited by 952
HIV reproducibly establishes a latent infection after acute infection of T cells in vitro
Jordan, A., Bisgrove, D., & Verdin, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg188 · Cited by 914
Self-citationDavey, R. T., Bhat, N., Yoder, C., Chun, T.-W., Metcalf, J. A., Dewar, R., Natarajan, V., Lempicki, R. A., Adelsberger, J. W., Miller, K. D., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15109 · Cited by 849
CREB-binding protein/p300 are transcriptional coactivators of p65
Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., & Collins, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2927 · Cited by 816
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Palmer, S., Maldarelli, F., Wiegand, A., Bernstein, B., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., & King, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800050105 · Cited by 638
Miyoshi, H., Smith, K. A., Mosier, D. E., Verma, I. M., & Torbett, B. E. (1999) · Science · doi:10.1126/science.283.5402.682 · Cited by 624
Emerging Concepts in the Immunopathogenesis of AIDS
Douek, D. C., Roederer, M., & Koup, R. A. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123549 · Cited by 612
Van Lint, C., Emiliani, S., Ott, M., & Verdin, E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00449.x · Cited by 580
Self-citationHIV disease: fallout from a mucosal catastrophe?
Brenchley, J. M., Price, D. A., & Douek, D. C. (2006) · Nature Immunology · doi:10.1038/ni1316 · Cited by 579
Clouse, K. A., Powell, D., Washington, I., Poli, G., Strebel, K., Farrar, W., Barstad, P., Kovacs, J., Fauci, A. S., & Folks, T. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.431 · Cited by 542
Jordan, A., Defechereux, P., & Verdin, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1726 · Cited by 467
Self-citationRamratnam, B., Mittler, J. E., Zhang, L., Boden, D., Hurley, A., Fang, F., Macken, C. A., Perelson, A. S., Markowitz, M., & Ho, D. D. (2000) · Nature Medicine · doi:10.1038/71577 · Cited by 452
NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation
Williams, S. A., Chen, L., Kwon, H., Ruiz‐Jarabo, C. M., Verdin, E., & Greene, W. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 430
Self-citationSharkey, M. E., Teo, I., Greenough, T., Sharova, N., Luzuriaga, K., Sullivan, J. L., Bucy, R. P., Kostrikis, L. G., Haase, A., Veryard, C., et al. (2000) · Nature Medicine · doi:10.1038/71569 · Cited by 428
Bailey, J. R., Sedaghat, A. R., Kieffer, T., Brennan, T., Lee, P. K., Wind-Rotolo, M., Haggerty, C. M., Kamireddi, A. R., Liu, Y., Lee, J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00591-06 · Cited by 417
HIV-1 Tat transcriptional activity is regulated by acetylation
Kiernan, R. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.6106 · Cited by 416
Chun, T.-W., Engel, D., Mizell, S. B., Hallahan, C. W., Fischette, M., Park, S., Davey, R. T., Dybul, M., Kovacs, J. A., Metcalf, J. A., et al. (1999) · Nature Medicine · doi:10.1038/9498 · Cited by 404
Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing
Marban, C., Suzanne, S., Dequiedt, F., de Walque, S., Redel, L., Van Lint, C., Aunis, D., & Rohr, O. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601516 · Cited by 354
Self-citationInduction of HIV-1 latency and reactivation in primary memory CD4+ T cells
Bosque, A., & Planelles, V. (2009) · Blood · doi:10.1182/blood-2008-07-168393 · Cited by 340
Kulkosky, J., Culnan, D. M., Roman, J., Dornadula, G., Schnell, M., Boyd, M. R., & Pomerantz, R. J. (2001) · Blood · doi:10.1182/blood.v98.10.3006 · Cited by 329
Han, Y., Lassen, K., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., & Siliciano, J. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6122-6133.2004 · Cited by 327
Folks, T. M., Justement, J., Kinter, A., Schnittman, S., Orenstein, J., Poli, G., & Fauci, A. S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.4.1117 · Cited by 315
Chéné, I. D., Basyuk, E., Lin, Y., Triboulet, R., Knezevich, A., Chable‐Bessia, C., Mettling, C., Baillat, V., Reynes, J., Corbeau, P., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601517 · Cited by 312
Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9
Mutskov, V., & Felsenfeld, G. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600013 · Cited by 296
HIV rebounds from latently infected cells, rather than from continuing low-level replication
Joos, B., Fischer, M., Kuster, H., Pillai, S. K., Wong, J. K., Böni, J., Hirschel, B., Weber, R., Trkola, A., Günthard, H. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804192105 · Cited by 294
Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription
Lewinski, M. K., Bisgrove, D., Shinn, P., Chen, H., Hoffmann, C., Hannenhalli, S., Verdin, E., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6610-6619.2005 · Cited by 270
Self-citationStrain, M. C., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Smith, D. M., Leigh-Brown, A. J., Macaranas, T. R., Lam, R. Y., Daly, O. A., Fischer, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0736332100 · Cited by 254
Wang, F.-X., Xu, Y., Sullivan, J., Souder, E., Argyris, E. G., Acheampong, E. A., Fisher, J., Sierra, M., Thomson, M. M., Najera, R., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522574 · Cited by 252
He, G., & Margolis, D. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2965-2973.2002 · Cited by 240
Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?
Blanchard, F., & Chipoy, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03309-4 · Cited by 239
Koiwa, T., Hamano-Usami, A., Ishida, T., Okayama, A., Yamaguchi, K., Kamihira, S., & Watanabe, T. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9389-9397.2002 · Cited by 235
Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells
Kinoshita, S., Chen, B. K., Kaneshima, H., & Nolan, G. P. (1998) · Cell · doi:10.1016/s0092-8674(00)81630-x · Cited by 227
Lavie, L., Kitova, M., Maldener, E., Meese, E., & Mayer, J. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.876-883.2005 · Cited by 225
CBF‐1 promotes transcriptional silencing during the establishment of HIV‐1 latency
Tyagi, M., & Karn, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601928 · Cited by 220
Harbers, K., Schnieke, A., Stuhlmann, H., Jähner, D., & Jaenisch, R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7609 · Cited by 217
Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms
Taniguchi, Y., Nosaka, K., Yasunaga, J.-I., Maeda, M., Mueller, N., Okayama, A., & Matsuoka, M. (2005) · Retrovirology · doi:10.1186/1742-4690-2-64 · Cited by 209
Molecular Characterization, Reactivation, and Depletion of Latent HIV
Brooks, D. G., Hamer, D. H., Arlen, P. A., Gao, L., Bristol, G., Kitchen, C. M. R., Berger, E. A., & Zack, J. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00236-x · Cited by 192
The SWI/SNF Chromatin-remodeling Complex Is a Cofactor for Tat Transactivation of the HIV Promoter
Mahmoudi, T., Parra, M., Vries, R. G. J., Kauder, S. E., Verrijzer, C. P., Ott, M., & Verdin, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603336200 · Cited by 182
Self-citationTréand, C., du Chéné, I., Brès, V., Kiernan, R., Benarous, R., Benkirane, M., & Emiliani, S. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601074 · Cited by 179
Chun, T.-W., Justement, J. S., Lempicki, R. A., Yang, J., Dennis, G., Hallahan, C. W., Sanford, C., Pandya, P., Liu, S., McLaughlin, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437640100 · Cited by 177
Kutsch, O., Benveniste, E. N., Shaw, G. M., & Levy, D. N. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8776-8786.2002 · Cited by 168
Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
Folks, T., Kelly, J., Benn, S., Kinter, A., Justement, J., Gold, J., Redfield, R., Sell, K. W., & Fauci, A. S. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4049 · Cited by 164
Lassen, K. G., Bailey, J. R., & Siliciano, R. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.9105-9114.2004 · Cited by 164
Sánchez, G., Xu, X., Chermann, J., & Hirsch, I. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2233-2240.1997 · Cited by 162
Self-citationRetrovirus vector silencing is de novo methylase independent and marked by a repressive histone code
Pannell, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5884 · Cited by 158
Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency.
Bednarik, D. P., Cook, J. A., & Pitha, P. M. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08222.x · Cited by 149
van Praag, R. M. E., Prins, J. M., Roos, M. T. L., Schellekens, P. T. A., ten Berge, I. J. M., Yong, S. L., Schuitemaker, H., Eerenberg, A. J. M., Jurriaans, S., de Wolf, F., et al. (2001) · Journal of Clinical Immunology · doi:10.1023/a:1011091300321 · Cited by 140
Robbins, P. B., Skelton, D. C., Yu, X., Halene, S., Leonard, E. H., & Kohn, D. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10182 · Cited by 139
DNA-Methylation Analysis by the Bisulfite-Assisted Genomic Sequencing Method
Hájková, P., El‐Maarri, O., Engemann, S., Oswald, J., Olek, A., & Walter, J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-182-5:143 · Cited by 122
Imamichi, H., Crandall, K. A., Natarajan, V., Jiang, M., Dewar, R. L., Berg, S. C., Gaddam, A., Bosche, M. C., Metcalf, J. A., Davey, R. T., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/317641 · Cited by 117
CpG methylation suppresses transcriptional activity of human syncytin-1 in non-placental tissues
Matoušková, M., Blažková, J., Pajer, P., Pavlı́ček, A., & Hejnar, J. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.010 · Cited by 115
Self-citationDeterminants of the Establishment of Human Immunodeficiency Virus Type 1 Latency
Duverger, A. E., Jones, J., May, J. E., Bibollet‐Ruche, F., Wagner, F. A., Cron, R. Q., & Kutsch, O. (2009) · Journal of Virology · doi:10.1128/jvi.02058-08 · Cited by 115
Ducrey, O., Guyader, M., & Trono, D. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9103-9111.2002 · Cited by 114
Lin, X., Irwin, D., Kanazawa, S., Huang, L., Romeo, J. M., Yen, T. S. B., & Peterlin, B. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8227-8236.2003 · Cited by 105
Ghose, R., Liou, L., Herrmann, C. H., & Rice, A. P. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11336-11343.2001 · Cited by 105
Biancotto, A., Grivel, J., Gondois‐Rey, F., Bettendroffer, L., Vigne, R., Brown, S., Margolis, L. B., & Hirsch, I. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10507-10515.2004 · Cited by 103
Self-citationIshida, T., Hamano, A., Koiwa, T., & Watanabe, T. (2006) · Retrovirology · doi:10.1186/1742-4690-3-69 · Cited by 87
Brenchley, J. M., Ruff, L. E., Casazza, J. P., Koup, R. A., Price, D. A., & Douek, D. C. (2006) · Journal of Virology · doi:10.1128/jvi.00070-06 · Cited by 76
Hejnar, J., Hájková, P., Plachý, J., Elleder, D., Stepanets, V., & Svoboda, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.565 · Cited by 57
Self-citationPion, M., Jordan, A., Biancotto, A., Dequiedt, F., Gondois‐Rey, F., Rondeau, S., Vigne, R., Hejnar, J., Verdin, E. M., & Hirsch, I. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4025-4032.2003 · Cited by 57
Self-citationIsolation of a cellular factor that can reactivate latent HIV-1 without T cell activation
Yang, H., Shen, L., Siliciano, R. F., & Pomerantz, J. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809536106 · Cited by 51
Hejnar, J., Plachý, J., Geryk, J., Machoň, O., Trejbalová, K., Guntaka, R. V., & Svoboda, J. (1999) · Virology · doi:10.1006/viro.1998.9597 · Cited by 30
Self-citationSingh, M. K., & Pauza, C. D. (1992) · Virology · doi:10.1016/0042-6822(92)90498-e · Cited by 25
Gondois‐Rey, F., Biancotto, A., Fernandez, M. A., Bettendroffer, L., Blažková, J., Trejbalová, K., Pion, M., & Hirsch, I. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.854-865.2006 · Cited by 12
Self-citationPion, M., Sánchez, G., Liška, V., Bettendroffer, L., Candotti, D., Chenine, A.-L., Gondois‐Rey, F., Tamalet, C., Vigne, R., Ruprecht, R. M., et al. (2003) · Virology · doi:10.1016/s0042-6822(03)00188-0 · Cited by 5
Self-citation
Cited by
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
Eriksson, S., Graf, E. H., Dahl, V., Strain, M. C., Yukl, S. A., Lysenko, E. S., Bosch, R. J., Lai, J., Chioma, S., Emad, F., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003174 · Cited by 567
Towards an HIV cure: a global scientific strategy
The International AIDS Society Scientific Working Group on HIV Cure (2012) · Nature Reviews Immunology · doi:10.1038/nri3262 · Cited by 554
Siliciano, R. F., & Greene, W. C. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007096 · Cited by 513
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Eisele, E., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.010 · Cited by 474
Metadata
- Authors
- Blazkova, J., Trejbalova, K., Gondois-Rey, F., Halfon, P., Philibert, P., Guiguen, A., Verdin, E., Olive, D., Van Lint, C., Hejnar, J., & Hirsch, I.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-08-21
- Volume
- 5
- Issue
- 8
- Pages
- e1000554
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2781948754
- Cited by
- 333
- References
- 70
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.